News and Insights

Dr. Terra Wonsettler makes the case for integrating cardiovascular care into cancer treatment, given the toxic effects of some therapies on the heart.

Amidst advances in therapies and technology, the core need for clinical oncology pathways remains, writes our chief medical officer.

Dr. Sadie Dobrozsi speaks with Newsweek about the need to identify any predisposition for cancer and undergo screening accordingly.

Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth.

Writing in Evidence-Based Oncology, Evolent’s vice president of pharmacy highlights the challenges around ensuring that “fast-track” cancer therapies deliver on their initial promise.

Could generative AI replace expert consensus for devising clinical guidelines? Our chief medical officer takes a look.

To reduce the fragmentation of care for complex conditions, we need to take on the fee-for-service models that contribute to it, says Evolent’s Dr. Vishnukamal Golla.

A stronger, unified voice in our scientific community will impact the accessibility of genetic testing so that it becomes standard preventive care for everyone who qualifies — and who wants it.